Mark Drugs Limited
About Mark Drugs Limited
Data last updated: 25 February 2026
Mark Drugs Limited is a public limited company based in Na, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 18 January 1995, the company has been in operation for over 31 years.
Registered with ROC Hyderabad under CIN U24239AP1995PLC019228.
Capital: an authorised share capital of ₹60 Lakh and a paid-up capital of ₹42.06 Lakh. It is led by directors Anandam Dyavanapally and Rajalingam Dyavanapalli.
Office: N – 1 – 192 Viveknagarchikkadpally Hyderabad, Telangana, India.
As per MCA filings, the company has open charges of ₹36 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressN – 1 – 192 Viveknagarchikkadpally Hyderabad, Telangana, India
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Mark Drugs Limited
Mark Drugs Limited has one previous CIN (Corporate Identification Number): U24239AP1995PLC019228. The current CIN is U24239TG1995PLC019228, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1995PLC019228 | Current |
| U24239AP1995PLC019228 | Previous |
Board of Directors of Mark Drugs Limited
Mark Drugs Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anandam Dyavanapally | Director | 18 Jan 1995 | 31 Years 6 Months | Current |
| Rajalingam Dyavanapalli | Director | 18 Jan 1995 | 31 Years 6 Months | Current |
Financials of Mark Drugs Limited
Ten-year financial statements for Mark Drugs Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mark Drugs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 1999 | Canara Bank | ₹18 Lakh | Open |
| 22 Feb 1997 | Canara Bank | ₹18 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Mark Drugs Limited
View historical data on people associated with Mark Drugs Limited, including employment history and EPFO contributions.
Employee and EPFO history for Mark Drugs Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Mark Drugs Limited
GST registrations and filing compliance for Mark Drugs Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Mark Drugs Limited
Credit ratings, litigation, and regulatory alerts for Mark Drugs Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mark Drugs Limited
MSME payment history for Mark Drugs Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mark Drugs Limited
Corporate group structure for Mark Drugs Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mark Drugs Limited
MCA filings and documents for Mark Drugs Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Mark Drugs Limited
Frequently Asked Questions about Mark Drugs Limited
Mark Drugs Limited is an active public limited company in the pharma sector based in Na, Telangana, India. It was incorporated on 18 January 1995 (31+ years old) and is registered under CIN U24239TG1995PLC019228.
The current directors of Mark Drugs Limited are:
- Anandam Dyavanapally - Director
- Rajalingam Dyavanapalli - Director
The primary industry of Mark Drugs Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Mark Drugs Limited can be reached at the registered office: N – 1 – 192 Viveknagarchikkadpally Hyderabad, Telangana, India.
The authorised capital is ₹60 Lakh, and the paid-up capital is ₹42.06 Lakh.
The company has its registered office at N – 1 – 192 Viveknagarchikkadpally Hyderabad, Telangana, India.